In the News

1855 News Items found
Caring Canine Plum
“Plum” from the Caring Canines program will compete June 11-13.
Five MSK researcher headshots
Read about the latest findings in immunotherapy from the 2021 annual meeting of the American Society of Clinical Oncology (ASCO).
Photo of Chadwick Boseman
Black adults are more likely to get colorectal cancer and die from it than any other group. Learn how Black men and women can protect themselves and why screening for colorectal cancer beginning at age 45 is so important.
Man in his 70s (prostate cancer patient) smiling for camera
A new treatment that selectively seeks out prostate cancer cells shows great promise for treating advanced forms of the disease.
Bob Li, MD, PhD, MPH
Memorial Sloan Kettering’s Bob Li served as principal investigator of the CodeBreaK 100 trial, the largest clinical trial conducted to date exclusively for patients with the KRAS G12C mutation.
Riya Agrawal
Feature
Each year, MSK offers a one-day radiology intensive and six-week paid internships to high school students across New York City.
Adelle Vice, MSK Registered Nurse
Memorial Sloan Kettering (MSK)’s Department of Marketing & Communications was awarded the Silver Award for Most Effective Media Plan in the 2021 Campaign US Media Awards.
Sloan Kettering Institute immunologists Joseph Sun and Sam Sheppard
Sloan Kettering Institute scientists are understanding more about natural killer (NK) cells, which are your allies when it comes to fighting infections and cancer.
Rev. Paul Yoon holding his infant son and standing with his wife
Meet Paul Yoon, Program Coordinator of Spiritual Care at Memorial Sloan Kettering, who immigrated to the US from South Korea, survived cancer, and is navigating his concerns around violence against Asian Americans.
Memorial Sloan Kettering medical oncologist Michael Morris
A newly approved imaging technology can identify the location of prostate cancer cells, allowing doctors to choose the best treatment.